The objective of this proposal is to study the role of cell and membrane lipid composition on the response of tumor cells to hyperthermia and to one form of chemotherapy. In previous experiments we have observed that thermotolerance can be induced in the L1210 murine leukemia cell by a gradual heating process. Since this technique affords the opportunity to alter thermal sensitivity in an incremental manner, one can use it to study the mechanism of thermotolerance and the mechanism of heat killing. In this regard we propose to further characterize this process and to expand our previous studies of the role of membrane lipids. We will correlate heat sensitivity in this system with the presence of heat shock protein. We will examine the influence of prior membrane fatty acid modification on the ability to develop thermotolerance since it affects thermal sensitivity. Furthermore, we will determine the role of intracellular pH in thermotolerance and heat sensitivity since there is evidence for a major role of intracellular proton concentration in cellular proliferation and in heat sensitivity. The ability of a membrane fluidizing drug, procaine, to synergize with heat will be explored as a means of further implicating the membrane. In a second aspect of the application, we propose to further characterize our recent observation that the sensitivity of neoplastic cells to anthracycline drug is markedly enhanced by increasing membrane polyunsaturation. We will attempt to determine the mechanism of this effect by studying lipid structure of the membrane and the effect of lipid polyunsaturation on adriamycin transport. Selected studies on two relevant human cell lines will also be carried out. Our long term objective is to determine the role of the-plasma membrane in experimental therapeutics.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA031526-06
Application #
3169640
Study Section
Experimental Therapeutics Subcommittee 2 (ET)
Project Start
1985-04-01
Project End
1988-03-31
Budget Start
1987-04-01
Budget End
1988-03-31
Support Year
6
Fiscal Year
1987
Total Cost
Indirect Cost
Name
University of Iowa
Department
Type
Schools of Medicine
DUNS #
041294109
City
Iowa City
State
IA
Country
United States
Zip Code
52242
Kelley, E E; Buettner, G R; Burns, C P (1995) Relative alpha-tocopherol deficiency in cultured cells: free radical-mediated lipid peroxidation, lipid oxidizability, and cellular polyunsaturated fatty acid content. Arch Biochem Biophys 319:102-9
Wagner, B A; Buettner, G R; Burns, C P (1994) Free radical-mediated lipid peroxidation in cells: oxidizability is a function of cell lipid bis-allylic hydrogen content. Biochemistry 33:4449-53
Wagner, B A; Buettner, G R; Burns, C P (1993) Increased generation of lipid-derived and ascorbate free radicals by L1210 cells exposed to the ether lipid edelfosine. Cancer Res 53:711-3
Kelley, E E; Modest, E J; Burns, C P (1993) Unidirectional membrane uptake of the ether lipid antineoplastic agent edelfosine by L1210 cells. Biochem Pharmacol 45:2435-9
Buettner, G R; Kelley, E E; Burns, C P (1993) Membrane lipid free radicals produced from L1210 murine leukemia cells by photofrin photosensitization: an electron paramagnetic resonance spin trapping study. Cancer Res 53:3670-3
Wagner, B A; Buettner, G R; Burns, C P (1992) Membrane peroxidative damage enhancement by the ether lipid class of antineoplastic agents. Cancer Res 52:6045-51
Petersen, E S; Kelley, E E; Modest, E J et al. (1992) Membrane lipid modification and sensitivity of leukemic cells to the thioether lipid analogue BM 41.440. Cancer Res 52:6263-9
Burns, C P; Wagner, B A (1991) Heightened susceptibility of fish oil polyunsaturate-enriched neoplastic cells to ethane generation during lipid peroxidation. J Lipid Res 32:79-87
Burns, C P; Petersen, E S (1990) Effect of butylated hydroxytoluene on bilineage differentiation of the human HL-60 myeloblastic leukemia cell. J Cell Physiol 144:36-41
Burns, C P; Spector, A A (1990) Effects of lipids on cancer therapy. Nutr Rev 48:233-40

Showing the most recent 10 out of 23 publications